Lee Kaplan, chief of obesity medicine at Dartmouth, said the approach should be more of a marathon than a sprint
Glucagon-like Peptide-1 (GLP-1) Agonists Drugs Uptake This section focuses on the uptake rate of potential Glucagon-like Peptide-1 (GLP-1) Agonists already launched and expected to be launched in the GLP-1 agonists therapy market during 20202034, which depends on the competitive landscape, safety, efficacy data, and order of entry
Like any medication, Wegovy side effects can occur, especially during the first few weeks
Some diabetes medications, including sulfonylureas and insulin, may interact with GLP-1 medications and increase the risk of hypoglycemia
Read More Direction for Use/Dosage Take one tablet daily with a meal or as directed by your healthcare provider